NASDAQ:MLAB - Mesa Laboratories Stock Price, Price Target & More

$169.00 -0.42 (-0.25 %)

(As of 04/20/2018 04:00 PM ET)

Previous Close$169.00

Today's Range$168.10 - $170.73

52-Week Range$122.35 - $170.96

Volume11,274 shs

Average Volume20,726 shs

Market Capitalization$640.94 million

P/E Ratio40.05

Dividend Yield0.38%

Beta0.51

About Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling, and semiconductor industries. Its Biological Indicators segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and testing services. This segment also distributes chemical indicators that are used to assess the effectiveness of sterilization processes, including steam, hydrogen peroxide, ethylene oxide, and radiation. The company's Cold Chain Monitoring segment offers systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and various other laboratory and industrial environments; and parameter monitoring services for products in a cold chain. Its Cold Chain Packaging segment offers packaging development consulting services and thermal packaging products. The company markets its products through distributors in the United States, Europe, Africa, Asia, South America, Australia, Canada, and Central America. Mesa Laboratories, Inc. was founded in 1982 and is headquartered in Lakewood, Colorado.

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Process control instruments

Sub-IndustryElectronic Equipment & Instruments

SectorMedical

SymbolNASDAQ:MLAB

CUSIP59064R10

Webwww.mesalabs.com

Phone303-987-8000

Debt

Debt-to-Equity Ratio0.58%

Current Ratio2.37%

Quick Ratio1.64%

Price-To-Earnings

Trailing P/E Ratio40.05

Forward P/E Ratio29.86

P/E GrowthN/A

Sales & Book Value

Annual Sales$93.67 million

Price / Sales6.82

Cash Flow$6.7277 per share

Price / Cash25.12

Book Value$26.43 per share

Price / Book6.39

Profitability

EPS (Most Recent Fiscal Year)$4.22

Net Income$11.18 million

Net Margins-3.82%

Return on Equity9.20%

Return on Assets5.37%

Miscellaneous

Employees381

Outstanding Shares3,780,000

How to Become a New Pot Stock Millionaire

Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories announced a quarterly dividend on Wednesday, April 4th. Investors of record on Thursday, May 31st will be given a dividend of $0.16 per share on Friday, June 15th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date of this dividend is Wednesday, May 30th. View Mesa Laboratories' Dividend History.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) released its quarterly earnings results on Monday, February, 5th. The medical instruments supplier reported ($0.24) EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.53 by $0.77. The medical instruments supplier earned $23.67 million during the quarter, compared to analyst estimates of $23.10 million. Mesa Laboratories had a positive return on equity of 9.20% and a negative net margin of 3.82%. View Mesa Laboratories' Earnings History.

When is Mesa Laboratories' next earnings date?

Mesa Laboratories is scheduled to release their next quarterly earnings announcement on Tuesday, June, 5th 2018. View Earnings Estimates for Mesa Laboratories.

Who are some of Mesa Laboratories' key competitors?

Some companies that are related to Mesa Laboratories include Brookdale Senior Living (BKD), TherapeuticsMD (TXMD), Myovant Sciences (MYOV), Endo International (ENDP), G1 Therapeutics (GTHX), Cellectis (CLLS), REGENXBIO (RGNX), Intersect ENT (XENT), Revance Therapeutics (RVNC), Apellis Pharmaceuticals (APLS), Theravance Biopharma (TBPH), Mallinckrodt (MNK), Natus Medical (BABY), PTC Therapeutics (PTCT), WAVE Life Sciences (WVE), U.S. Physical Therapy (USPH), ATRION (ATRI) and Dynavax Technologies (DVAX).

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the folowing people:

Mr. Gary M. Owens, CEO, Pres & Director (Age 50)
Mr. John V. Sakys, Chief Financial & Chief Accounting Officer, Sec. and Treasurer (Age 49)
Mr. Glenn E. Adriance, Chief Sales & Marketing Officer (Age 64)
Mr. Bryan T. Leo, Sr. VP of Operations
Mr. Garrett Krushefski, Sr. VP of Operations

Has Mesa Laboratories been receiving favorable news coverage?

News stories about MLAB stock have been trending somewhat positive this week, according to Accern. Accern rates the sentiment of media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Mesa Laboratories earned a news sentiment score of 0.19 on Accern's scale. They also gave news articles about the medical instruments supplier an impact score of 46.79 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $169.00.

How big of a company is Mesa Laboratories?

Mesa Laboratories has a market capitalization of $640.94 million and generates $93.67 million in revenue each year. The medical instruments supplier earns $11.18 million in net income (profit) each year or $4.22 on an earnings per share basis. Mesa Laboratories employs 381 workers across the globe.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]

MarketBeat Community Rating for Mesa Laboratories (MLAB)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		105 (Thanks for Voting!)
Underperform Votes:		96 (Thanks for Voting!)
Total Votes:		201

MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe MLAB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MLAB will underperform the S&P 500 over the long term. You may vote once every thirty days.

Mesa Laboratories (NASDAQ:MLAB) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	N/A	N/A	N/A	Buy
Consensus Rating Score:	N/A	N/A	N/A	3.00
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	N/A	N/A	N/A	N/A
Price Target Upside:	N/A	N/A	N/A	N/A

Mesa Laboratories (NASDAQ:MLAB) Consensus Price Target History

Price Target History for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ:MLAB) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
12/23/2016	Janney Montgomery Scott	Reiterated Rating	Buy		N/A
6/10/2016	Sidoti	Downgrade	Buy -> Neutral	$132.00	N/A

(Data available from 4/21/2016 forward)

Mesa Laboratories (NASDAQ:MLAB) Earnings History and Estimates Chart

Earnings by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ:MLAB) Earnings Estimates

Current Year EPS Consensus Estimate: $5.66 EPS
Next Year EPS Consensus Estimate: $6.71 EPS

Mesa Laboratories (NASDAQ MLAB) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
6/5/2018		$0.84					N/A
2/5/2018	Q3 2018	$0.53	($0.24)	$23.10 million	$23.67 million	View	N/A
11/6/2017	Q2 2018	$0.64	$0.60	$25.50 million	$22.95 million	View	N/A
7/31/2017	Q1 2018	$0.56	$0.39	$22.90 million	$22.67 million	View	N/A
6/7/2017	Q4 2017	$1.00	$1.24	$27.10 million	$24.30 million	View	N/A
2/2/2017	Q3 2017	$0.6150	$1.19	$22.60 million	$23.84 million	View	N/A
11/2/2016	Q217	$0.85	$0.92	$23.80 million	$24.40 million	View	N/A
7/28/2016	Q1	$0.89	$0.89	$21.20 million	$21.11 million	View	N/A
6/2/2016	Q4	$0.94	$1.33	$21.00 million	$24.81 million	View	N/A
2/2/2016	Q3 2016		$0.92		$19.91 million	View	N/A
11/2/2015	Q2 2016		$0.72		$21.78 million	View	N/A
8/3/2015	Q116	$0.83	$0.85	$18.78 billion	$18.20 billion	View	N/A
6/1/2015	Q415	$0.91	$0.80		$18.56 million	View	N/A
2/2/2015	Q315	$0.73	$0.87		$17.83 million	View	N/A
11/3/2014	Q215	$0.69	$0.84	$12.68 million	$18.54 million	View	N/A
8/6/2014	Q115	$0.67	$0.71	$11.22 million	$16.40 million	View	N/A
6/2/2014	Q414	$0.70	$1.15	$12.80 million	$15.70 million	View	N/A
2/3/2014	Q4		$0.62		$13.12 million	View	N/A
11/5/2013	Q2 2014		$0.65		$12.68 million	View	N/A
8/6/2013	Q1 2014		$0.63		$11.22 million	View	N/A
5/29/2013	Q113	$0.59	$0.76	$13.13 million	$12.81 million	View	N/A
2/5/2013	Q3 2013	$0.67	$0.56	$11.76 million	$11.36 million	View	N/A
11/8/2012	Q312	$0.61	$0.76	$11.48 million	$11.71 million	View	N/A
8/9/2012	Q1 2013		$0.70			View	N/A
5/23/2012	Q4 2012		$0.76			View	N/A
2/8/2012	Q3 2012		$0.63			View	N/A
11/9/2011	Q2 2012		$0.66			View	N/A
8/10/2011	Q1 2012		$0.56			View	N/A
6/8/2011	Q4 2011		$0.71			View	N/A
2/14/2011	Q3 2011		$0.43			View	N/A
11/10/2010	Q2 2011		$0.48			View	N/A
8/16/2010	Q1 2011		$0.44			View	N/A
5/25/2010	Q4 2010		$0.40			View	N/A
2/11/2010	Q3 2010		$0.35			View	N/A
11/12/2009	Q2 2010		$0.38			View	N/A
8/11/2009	Q1 2010		$0.31			View	N/A
5/26/2009	Q4 2009		$0.37			View	N/A
2/10/2009	Q3 2009		$0.38			View	N/A
11/10/2008	Q2 2009		$0.42			View	N/A
8/12/2008	Q1 2009		$0.31			View	N/A
5/19/2008	Q4 2008		$0.36			View	N/A
2/11/2008	Q3 2008		$0.34			View	N/A

(Earnings results data provided by Zacks Investment Research)

Mesa Laboratories (NASDAQ:MLAB) Dividend Information

Mesa Laboratories pays an annual dividend of $0.64 per share, with a dividend yield of 0.38%. MLAB's next quarterly dividend payment will be made on Friday, June 15. Mesa Laboratories pays out 15.17% of its earnings out as a dividend.

Next Dividend:	6/15/2018
Annual Dividend:	$0.64
Dividend Yield:	0.38%
Dividend Growth:	1.60% (3 Year Average)
Payout Ratio:	15.17% (Trailing 12 Months of Earnings) 11.31% (Based on This Year's Estimates) 9.54% (Based on Next Year's Estimates)
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ:MLAB) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/4/2018	Quarterly	$0.16	0.42%	5/30/2018	5/31/2018	6/15/2018
1/2/2018	Quarterly	$0.16	0.51%	2/27/2018	2/28/2018	3/15/2018
10/3/2017	quarterly	$0.16	0.42%	11/29/2017	11/30/2017	12/15/2017
7/6/2017	quarterly	$0.16	0.45%	8/29/2017	8/31/2017	9/15/2017
4/6/2017	quarterly	$0.16	0.5%	5/26/2017	5/31/2017	6/15/2017
1/4/2017	quarterly	$0.16	0.51%	2/24/2017	2/28/2017	3/15/2017
10/5/2016	quarterly	$0.16	0.54%	11/28/2016	11/30/2016	12/15/2016
7/7/2016	quarterly	$0.16	0.52%	8/29/2016	8/31/2016	9/15/2016
4/13/2016	quarterly	$0.16	0.64%	5/26/2016	5/31/2016	6/15/2016
1/6/2016	quarterly	$0.16	0.71%	2/25/2016	2/29/2016	3/15/2016
10/5/2015	quarterly	$0.16	0.57%	11/25/2015	11/30/2015	12/15/2015
7/9/2015	quarterly	$0.16	0.72%	8/27/2015	8/31/2015	9/15/2015
4/3/2015	quarterly	$0.16	0.93%	5/27/2015	5/29/2015	6/15/2015
1/7/2015	quarterly	$0.16	0.84%	2/25/2015	2/27/2015	3/16/2015
10/14/2014	quarterly	$0.16	0.95%	11/25/2014	11/28/2014	12/15/2014
7/17/2014	quarterly	$0.15	0.73%	8/27/2014	8/29/2014	9/15/2014
4/23/2014	quarterly	$0.15	0.69%	5/28/2014	5/30/2014	6/16/2014
1/31/2014	quarterly	$0.15	0.75%	2/26/2014	2/28/2014	3/17/2014
11/1/2013	quarterly	$0.15	0.88%	11/26/2013	11/29/2013	12/16/2013
8/7/2013	quarterly	$0.14	0.92%	8/28/2013	8/30/2013	9/18/2013
4/18/2013	quarterly	$0.14	1.1%	5/22/2013	5/27/2013	6/24/2013
4/17/2013	quarterly	$0.14			5/27/2013	6/14/2013
2/6/2013	quarterly	$0.14	1.08%	2/25/2013	2/27/2013	3/15/2013

(Data available from 1/1/2013 forward)

Mesa Laboratories (NASDAQ MLAB) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 15.70%
Institutional Ownership Percentage: 72.93%

Insider Trading History for Mesa Laboratories (NASDAQ:MLAB)

Institutional Ownership by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Mesa Laboratories (NASDAQ MLAB) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/14/2018	Robert V Dwyer	Director	Sell	5,000	$144.01	$720,050.00	68,521
2/16/2018	John James Sullivan	Director	Sell	4,000	$138.00	$552,000.00	72,248
2/8/2018	John Bradley Schmieder	Director	Sell	3,000	$132.27	$396,810.00	77,869
8/21/2017	H Stuart Campbell	Director	Sell	1,000	$130.16	$130,160.00	42,366
8/18/2017	H Stuart Campbell	Director	Sell	2,000	$130.42	$260,840.00	44,366
8/15/2017	H Stuart Campbell	Director	Sell	2	$134.10	$268.20	45,366
8/11/2017	H Stuart Campbell	Director	Sell	608	$134.08	$81,520.64	45,368
8/10/2017	H Stuart Campbell	Director	Sell	1,000	$136.58	$136,580.00	45,976
8/9/2017	H Stuart Campbell	Director	Sell	1,000	$137.61	$137,610.00	46,976
8/4/2017	H Stuart Campbell	Director	Sell	1,000	$143.09	$143,090.00	47,976
8/3/2017	H Stuart Campbell	Director	Sell	2,000	$143.37	$286,740.00	49,976
6/16/2017	Robert V Dwyer	Director	Sell	11,150	$139.46	$1,554,979.00	80,671
6/12/2017	David M Kelly	Director	Sell	1,000	$142.00	$142,000.00	4,750
6/9/2017	Glenn E Adriance	Insider	Sell	4,000	$148.98	$595,920.00	10,000
3/20/2017	Michael T Brooks	Director	Sell	2,000	$122.94	$245,880.00	28,900
2/22/2017	Robert V Dwyer	Director	Sell	5,000	$125.13	$625,650.00	87,971
2/21/2017	John James Sullivan	Insider	Sell	9,078	$124.83	$1,133,206.74	64,278
2/13/2017	John James Sullivan	CEO	Sell	5,922	$123.99	$734,268.78	68,040
2/7/2017	Glenn E Adriance	Insider	Sell	8,070	$124.15	$1,001,890.50	15,170
2/7/2017	H Stuart Campbell	Director	Sell	8,000	$121.55	$972,400.00	55,930
11/23/2016	Glenn E Adriance	Insider	Sell	3,567	$135.93	$484,862.31	15,525
11/17/2016	John Sakys	CFO	Sell	1,000	$127.14	$127,140.00	2,000
10/21/2016	H Stuart Campbell	Director	Sell	4,000	$119.02	$476,080.00	63,930
9/16/2016	H Stuart Campbell	Director	Sell	3,000	$115.03	$345,090.00	67,930
6/22/2016	John James Sullivan	CEO	Sell	4,000	$121.63	$486,520.00	66,118
6/6/2016	Glenn E Adriance	Insider	Sell	3,000	$111.74	$335,220.00	14,100
3/11/2016	H Stuart Campbell	Director	Sell	6,000	$86.32	$517,920.00	73,887
3/7/2016	H Stuart Campbell	Director	Sell	280	$90.00	$25,200.00	76,071
2/24/2016	H Stuart Campbell	Director	Sell	1,532	$92.90	$142,322.80	79,766
11/6/2015	John James Sullivan	CEO	Sell	2,400	$112.99	$271,176.00	61,393
9/22/2015	H Stuart Campbell	Director	Buy	150	$109.54	$16,431.00	78,848
9/17/2015	Robert V Dwyer	Director	Sell	2,000	$113.00	$226,000.00	92,373
9/15/2015	Robert V Dwyer	Director	Sell	3,000	$111.67	$335,010.00	94,373
9/11/2015	Robert V Dwyer	Director	Sell	1,000	$110.00	$110,000.00	97,373
9/8/2015	Robert V Dwyer	Director	Sell	1,000	$110.39	$110,390.00	98,373
8/17/2015	Robert V Dwyer	Director	Sell	1,937	$116.50	$225,660.50
3/14/2014	Luke R Schmieder	Director	Sell	5,000	$90.04	$450,200.00
2/27/2014	Glenn E Adriance	Insider	Sell	1,000	$87.68	$87,680.00
2/25/2014	John James Sullivan	CEO	Sell	10,000	$87.01	$870,100.00
12/9/2013	Glenn E Adriance	Insider	Sell	4,825	$73.68	$355,506.00
11/15/2013	Robert V Dwyer	Director	Sell	13,476	$71.33	$961,243.08
11/14/2013	Robert V Dwyer	Director	Sell	6,524	$71.33	$465,356.92
8/19/2013	John James Sullivan	CEO	Sell	6,000	$64.87	$389,220.00
8/14/2013	John James Sullivan	CEO	Sell	6,000	$61.92	$371,520.00
3/5/2013	H Stuart Campbell	Director	Sell	30,000	$52.75	$1,582,500.00
12/27/2012	Steven W Peterson	CFO	Sell	17,054	$48.50	$827,119.00

(Data available from 1/1/2013 forward)

Mesa Laboratories (NASDAQ MLAB) News Headlines

Source:

Date	Headline
	Mesa Laboratories (MLAB) & Fortive (FTV) Head to Head Comparison www.americanbankingnews.com - April 17 at 1:35 AM
	Mesa Laboratories (MLAB) Cut to "Sell" at BidaskClub www.americanbankingnews.com - April 14 at 10:19 PM
	TheStreet Lowers Mesa Laboratories (MLAB) to C+ www.americanbankingnews.com - April 14 at 11:13 AM
	Zacks: Mesa Laboratories, Inc. (MLAB) Given Average Recommendation of "Strong Buy" by Brokerages www.americanbankingnews.com - April 13 at 1:49 PM
	Mesa Laboratories (MLAB) Rating Lowered to Strong Sell at Zacks Investment Research www.americanbankingnews.com - April 13 at 1:04 PM
	Sensata Technologies (ST) & Mesa Laboratories (MLAB) Critical Review www.americanbankingnews.com - April 11 at 5:33 AM
	Mesa Laboratories (MLAB) Upgraded to Buy at Zacks Investment Research www.americanbankingnews.com - April 8 at 10:23 AM
	Mesa Laboratories (MLAB) Lifted to "Strong-Buy" at BidaskClub www.americanbankingnews.com - April 7 at 9:29 AM
	ValuEngine Upgrades Mesa Laboratories (MLAB) to "Buy" www.americanbankingnews.com - April 3 at 12:10 PM
	Mesa Laboratories (MLAB) Rating Increased to B at TheStreet www.americanbankingnews.com - April 1 at 11:23 AM
	Mesa Laboratories (MLAB) Stock Rating Lowered by Zacks Investment Research www.americanbankingnews.com - March 31 at 4:56 PM
	Mesa Laboratories (MLAB) Upgraded at Zacks Investment Research www.americanbankingnews.com - March 30 at 9:17 AM
	Mesa Laboratories, Inc. (MLAB) Given $175.00 Average Target Price by Brokerages www.americanbankingnews.com - March 29 at 10:15 AM
	BidaskClub Lowers Mesa Laboratories (MLAB) to Sell www.americanbankingnews.com - March 26 at 1:58 PM
	Mesa Laboratories (MLAB) Rating Lowered to Sell at Zacks Investment Research www.americanbankingnews.com - March 26 at 12:45 PM
	Mesa Laboratories (MLAB) Upgraded at BidaskClub www.americanbankingnews.com - March 25 at 10:29 AM
	Mesa Laboratories (MLAB) Lifted to "Hold" at Zacks Investment Research www.americanbankingnews.com - March 24 at 6:46 PM
	Mesa Laboratories, Inc. (MLAB) Receives Consensus Recommendation of "Strong Buy" from Brokerages www.americanbankingnews.com - March 23 at 3:34 PM
	Insider Selling: Mesa Laboratories, Inc. (MLAB) Director Sells 5,000 Shares of Stock www.americanbankingnews.com - March 19 at 10:18 AM
	Mesa Laboratories, Inc. (MLAB) Given $175.00 Consensus Target Price by Brokerages www.americanbankingnews.com - March 18 at 9:28 AM
	Mesa Laboratories (MLAB) Upgraded by BidaskClub to "Buy" www.americanbankingnews.com - March 17 at 5:34 PM
	Mesa Laboratories, Inc. (MLAB) Position Lifted by Ranger Investment Management L.P. www.americanbankingnews.com - March 6 at 2:11 PM
	Brokerages Expect Mesa Laboratories, Inc. (MLAB) to Announce $0.76 EPS www.americanbankingnews.com - March 3 at 3:36 AM
	Mesa Laboratories, Inc. (MLAB) Shares Bought by King Luther Capital Management Corp www.americanbankingnews.com - February 28 at 1:19 PM
	Royce & Associates LP Has $9.79 Million Position in Mesa Laboratories, Inc. (MLAB) www.americanbankingnews.com - February 26 at 12:20 PM
	Investors In Mesa Laboratories Inc (NASDAQ:MLAB) Are Paying Above The Intrinsic Value finance.yahoo.com - February 23 at 5:34 PM
	John James Sullivan Sells 4,000 Shares of Mesa Laboratories, Inc. (MLAB) Stock www.americanbankingnews.com - February 20 at 12:16 PM
	Mesa Laboratories, Inc. (MLAB) Given Average Rating of "Strong Buy" by Analysts www.americanbankingnews.com - February 15 at 1:28 AM
	Mesa Laboratories (MLAB) Lowered to "C" at TheStreet www.americanbankingnews.com - February 10 at 1:56 PM
	Mesa Laboratories (MLAB) Downgraded by Zacks Investment Research to Sell www.americanbankingnews.com - February 10 at 6:28 AM
	Insider Selling: Mesa Laboratories, Inc. (MLAB) Director Sells 3,000 Shares of Stock www.americanbankingnews.com - February 8 at 6:16 PM
	CBMG Up 50% YTD, HAIR Keeps Falling, MNOV To Report NASH Trial Data In April www.nasdaq.com - February 8 at 8:27 AM
	Mesa Labs reports 3Q loss finance.yahoo.com - February 6 at 9:36 AM
	Are Mesa Laboratories Inc’s (NASDAQ:MLAB) Interest Costs Too High? finance.yahoo.com - January 31 at 10:04 AM
	Zacks: Mesa Laboratories, Inc. (MLAB) Receives Consensus Recommendation of "Strong Buy" from Brokerages www.americanbankingnews.com - January 31 at 5:16 AM
	Mesa Laboratories (MLAB) Set to Announce Quarterly Earnings on Wednesday www.americanbankingnews.com - January 24 at 3:56 AM
	Mesa Laboratories, Inc. (MLAB) Given Average Recommendation of "Strong Buy" by Analysts www.americanbankingnews.com - January 16 at 9:56 AM
	Rudolph Technologies (RTEC) versus Mesa Laboratories (MLAB) Head to Head Contrast www.americanbankingnews.com - January 11 at 3:34 PM
	Mesa Laboratories, Inc. to Issue Quarterly Dividend of $0.16 (MLAB) www.americanbankingnews.com - January 3 at 12:36 PM
	Mesa Labs Declares Quarterly Dividend finance.yahoo.com - January 2 at 6:58 PM
	Zacks: Analysts Set $175.00 Price Target for Mesa Laboratories, Inc. (MLAB) www.americanbankingnews.com - January 1 at 1:56 AM
	Head-To-Head Survey: MKS Instruments (MKSI) vs. Mesa Laboratories (MLAB) www.americanbankingnews.com - December 28 at 3:21 AM
	Head to Head Survey: Mesa Laboratories (MLAB) versus MKS Instruments (MKSI) www.americanbankingnews.com - December 28 at 3:21 AM
	Brokerages Expect Mesa Laboratories, Inc. (MLAB) to Announce $0.61 Earnings Per Share www.americanbankingnews.com - December 16 at 7:26 PM
	MKS Instruments (MKSI) and Mesa Laboratories (MLAB) Critical Contrast www.americanbankingnews.com - December 12 at 9:34 PM
	Analysts Expect Mesa Laboratories, Inc. (MLAB) to Post $0.61 EPS www.americanbankingnews.com - December 8 at 11:52 PM
	Mesa Laboratories, Inc. : MLAB-US: Dividend Analysis : November 30th, 2017 (record date) : By the numbers : November 30, 2017 finance.yahoo.com - November 30 at 5:30 PM
	Mesa Laboratories, Inc. (MLAB) Given $175.00 Average Price Target by Brokerages www.americanbankingnews.com - November 23 at 1:52 AM
	Mesa Laboratories, Inc. (MLAB) Given Consensus Rating of "Strong Buy" by Analysts www.americanbankingnews.com - November 19 at 9:26 PM
	Mesa Labs Acquires Sterilization and Disinfection Process Control Business finance.yahoo.com - November 9 at 5:37 AM

Mesa Laboratories (NASDAQ:MLAB) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Mesa Laboratories (NASDAQ:MLAB) Income Statement, Balance Sheet and Cash Flow Statement

Mesa Laboratories (NASDAQ MLAB) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff